NCT00575393View on ClinicalTrials.gov

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 25, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

February 14, 2012

Conditions
Lung Cancer
Interventions
DRUG

gold sodium thiomalate

GENETIC

gene expression analysis

OTHER

fluorine F 18 fluorothymidine

OTHER

mass spectrometry

OTHER

pharmacological study

Trial Locations (3)

32224

Mayo Clinic - Jacksonville, Jacksonville

55905

Mayo Clinic Cancer Center, Rochester

85259-5499

Mayo Clinic Scottsdale, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER